Products are for professional/laboratory use only. Gyros has developed a three-step bridging Gyrolab assay with a broad assay range (40 to 200,000ng/mL) for qualitative detection of total antibodies generated against the spike protein (RBD) of SARS-CoV-2 in human serum samples.
Impurity testing of biotherapeutics? Try the new Gyrolab CHO-HCP E3G Kit. Now available in a ready to use kit optimized for Gyrolab® Systems.